Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S26 pseudogene 59 (RPS26P59) is a processed pseudogene related to the functional ribosomal protein S26 gene but is not believed to encode a functional protein. Processed pseudogenes, including RPS26P59, are typically remnants of gene duplication or retrotransposition events and lack protein-coding ability. There is no evidence that RPS26P59 has known biological functions or disease associations, nor is it considered a druggable therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S26 pseudogene 59 (RPS26P59).